Table 3.
Functional and familial burden for psychosis
| Program (n = 48) | Control (n = 17) | ANCOVA | Full cohort T | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean | (SD) | Mean | (SD) | Effect size F, partial eta2 |
P-val* | Mean | (SD) | Effect Size Z, r |
P-val** | |
| WHODAS | 0.52, 0.01 | 0.52 | 4.60, 0.57 | < 0.0001 | ||||||
| Baseline | 46.1 | (24.2) | 37.4 | (25.6) | 43.8 | (24.7) | ||||
| end point | 23.1 | (20.8) | 27.1 | (30.9) | 24.1 | (23.7) | ||||
| Δ score | − 23.0 | (27.0) | − 10.3 | (44.3) | − 19.7 | (32.6) | ||||
| BAS | 0.29, < 0.01 | 0.59 | 6.81, 0.84 | < 0.0001 | ||||||
| Baseline | 76.5 | (8.0) | 76.0 | (8.2) | 76.4 | (8.0) | ||||
| end point | 63.3 | (6.5) | 62.1 | (9.3) | 62.9 | (7.3) | ||||
| Δ score | − 13.3 | (8.6) | − 13.9 | (11.5) | − 13.4 | (9.4) | ||||
| FIS: symptoms and social behavior | 0.16, < 0.01 | 0.69 | 5.94, 0.74 | < 0.0001 | ||||||
| Baseline | 46.5 | (9.7) | 41.2 | (11.4) | 45.1 | (10.4) | ||||
| end point | 31.1 | (9.4) | 31.6 | (11.0) | 31.2 | (9.8) | ||||
| Δ Score | − 15.4 | (12.3) | − 9.6 | (15.8) | − 13.9 | (13.4) | ||||
| FIS: impact on caregiver | 2.02, 0.03 | 0.16 | 5.13, 0.64 | < 0.0001 | ||||||
| Baseline | 12.0 | (5.9) | 10.9 | (6.3) | 11.7 | (6.0) | ||||
| end point | 5.9 | (4.3) | 7.6 | (5.7) | 6.3 | (4.7) | ||||
| Δ score | − 6.1 | (6.4) | − 3.3 | (7.9) | − 5.4 | (6.9) | ||||
WHODAS World Health Organization Disability Assessment Schedule 2.0 Short Version, BAS burden assessment schedule, FIS Family Interview Schedule
* P-value taken from ANCOVA (analysis of covariance) for each scale comparing program vs. control scores at end point, adjusted for baseline score
** P-value from Wilcoxon Signed-Rank Test comparing baseline to end point scores (full cohort)